Clinical trial
A Prospective, Randomized, Double Blind, Double-Dummy Study Comparing the Safety and Efficacy of Epsilon Aminocaproic Acid (eACA) Versus Tranexamic Acid (TXA) Versus Placebo for Prevention of Blood Loss in Total Knee Arthroplasty
NCT01527968 is registered in ClinicalTrials.gov with Heekin Orthopedic Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Double Blind, Double-Dummy Study Comparing the Safety and Efficacy of Epsilon Aminocaproic Acid (eACA) Versus Tranexamic Acid (TXA) Versus Placebo for Prevention of Blood Loss in Total Knee Arthroplasty
- Lead sponsor
- Heekin Orthopedic Research Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2012
- Completion date
- December 31, 2016
- Enrollment
- 54 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.